Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 33, Issue 1, Pages 1415-1429Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14756366.2018.1509210
Keywords
Disaccharide nucleosides; tyrosyl-DNA phosphodiesterase 1; TDP1 inhibitor; topotecan
Funding
- Russian Scientific Foundation [14-24-00038, 17-74-10057]
- Russian Science Foundation [17-24-00011, 17-74-10057] Funding Source: Russian Science Foundation
Ask authors/readers for more resources
A new class of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors based on disaccharide nucleosides was identified. TDP1 plays an essential role in the resistance of cancer cells to currently used antitumour drugs based on Top1 inhibitors such as topotecan and irinotecan. The most effective inhibitors investigated in this study have IC50 values (half-maximal inhibitory concentration) in 0.4-18.5 mu M range and demonstrate relatively low own cytotoxicity along with significant synergistic effect in combination with anti-cancer drug topotecan. Moreover, kinetic parameters of the enzymatic reaction and fluorescence anisotropy were measured using different types of DNA-biosensors to give a sufficient insight into the mechanism of inhibitor's action.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available